Another new publication from the lab and collaborators - Cardiotoxicity in autologous haematopoietic #stemcell transplantation for #systemicsclerosis https://t.co/02MyHkHtSX #Researchpaper#hsct
New publication! Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk chil… https://t.co/xZL6eUVrq8 #Leukemia#Cancer#Researchpaper
Congratulations Dr Jen Massey on your 2023 incubator grant from MS Australia as you continue to break ground with your research into MS! #MultipleSclerosis Thank you to the great team @MS_Australia for their support https://t.co/NxLX9zF7Pi
Proud of Prof John Moore and Dr Alisa Kane who are leading this work utilising allogeneic stem cell transplant in primary immunodeficiencies https://t.co/oGQCTB0qj7
@SVHSydney @SVH_BSCCR
We’re hiring! Please retweet. Research Scientist, Blood Stem Cell & Cancer Research, Sydney @SVH_BSCCR. Research assistants, Postdocs apply. Hematology, leukemia. Translational research, CHIP mutations, novel therapies, drug testing. Closes 3 April https://t.co/umYR0BZn73
John Moore presents 25 years of autologous stem cell transplantation for autoimmune disease @SVHSydney and >150 patients at @StVHealthAust Research Symposium @SVH_BSCCR
New publication: Ground breaking #telehealth trial for #cancer patients post #stemcell (HSCT) transplant at @SVHSydney - benefits of a virtual, home-based exercise and mindfulness training program for HSCT survivors https://t.co/cqPUxpbRu0
Just 2 weeks to go till St Vincent’s Research Symposium! 🤩
Make sure you’ve registered to hear about the amazing research that has been taking place on campus! 🧑🏻💻
Rego link: https://t.co/cObcJJ4z4f
New Research: Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis: Autologous haematopoietic stem cell transplantation (AHSCT) is a vital therapeutic option for… https://t.co/sogfPW8mj3 #immunology
We're thrilled to announce the upcoming 30th annual St Vincent's Campus Research Symposium #SVCRS2022 that will bring together talented researchers from across one of the largest medical research precincts in Australia @kinghorncancer@GarvanInstitute@VictorChangInst @SVHSydney
Potential Benefits of a 6-Week #Exercise and #Mindfulness-Based #Telehealth Training for #HCT Survivors to Meet the Challenges of the #COVID-19 Pandemic - a Feasibility Study https://t.co/oVgaqd1svA
#RealMSResearch coming from our lab - congratulations Dr Malini Visweswaran and to all the team on your new publication “Sustained immunotolerance in #multiple sclerosis after #stem cell transplant” https://t.co/ZcGmVOzkNX
Covid-19 has posed countless challenges for the #healthcare sector. Prof. Ma and collaborators have worked out how to transport and optimise #blood#StemCells for life-saving #transplants for patients during the pandemic, read here https://t.co/gmFJmfKfic @cytotherapy @SVHSydney
#CallToAction support direct comparisons of #iPSC#Blood methods + multiple endpoints =empower method selection! Ours: Best =2D-multistep more live, CD34+ & CFU progenitors, lowest cost & time, most sensitive genetic disorders https://t.co/zxE7nPZGII @SVCRSymposium#SVCRS2021 5/5
@SVH_BSSCR directly compared our 2DM #iPSC#Blood protocol to 3 distinct recently cited methods. Ours =most live cells, CD34+ & functional CFU blood progenitors. Cheapest & fastest to produce 1 million CD34+ & CFU functional progenitor cells, ANOVA @SVCRSymposium#SVCRS2021 3/5
Starting #iPSC#StemCell work in your lab & unsure which #Blood production method to use? Check here =direct comparison of 4 distinct serum/feeder-free methods +our method =one of the highest proportion of functional progenitors in literature WOW! @SVCRSymposium#SVCRS2021 1/5